Software checks
Three developer-run checks: the calculator’s arithmetic against an independently written reference calculation, its handling of a loading dose, and how often its 90% band contains the true concentration in synthetic patients. They test whether the software does what it describes. They do not show how accurately it predicts levels in real patients.
Calculator version 2026-09-25.1. All results on this page were run on this version.
A separate calculation was developed from the two-compartment equations and checked with another mathematical method. The calculator’s results were then compared with that reference. Agreement must be within one part in a million wherever both sides are exact.
| Section | What is compared | Size |
|---|---|---|
| A | Two separate mathematical calculations compared for single doses, repeated doses and steady state. | 71 checks |
| B | Published reference values for a typical adult (35 y, 70 kg, SCr 0.83 mg/dL; 1,000 mg q12h over 1.75 h). | 6 checks |
| C | Mathematical properties the solution must satisfy, such as mass balance, superposition and the steady-state limit. | 171 checks |
| D | The calculator against the reference calculation: starting estimates based on Colin 2019, the reference regimen, every test case (including slow elimination, q18h/q36h and 0.5–4 h infusions), 20 random adult regimens and the analytic AUC. | 6 groups |
| E | The loading-dose history against the reference: 40 random schedules (loading dose, infusion times, a shortened gap to the first maintenance dose, 2–7 doses), comparing concentrations, AUC, the trough and AUC after the selected dose, and the fit's predicted level. | 40 regimens |
Result on version 2026-09-25.1: 255 checks passed and no value differed from the reference by more than one part in a million. The same developer wrote both calculations, so a shared misreading of the model would not be caught; the comparison with Tucuxi uses a separately built program for that reason. Its Vancomyzer side was re-run on version 2026-09-25.1 and reproduces the published comparison exactly.
When using one or two blood levels, dose 1 can be entered as a loading dose with its own amount, infusion time and gap to the first maintenance dose. The fit to the measured levels then uses the doses actually given. If a loading dose is recorded as a maintenance dose instead, the extra drug is read as slow clearance and exposure is overestimated.
Example: a 60-year-old, 80 kg adult (SCr 1.0 mg/dL) on 1,000 mg every 12 h over 2 h, with one trough 11.5 h after the stated dose. Error in the calculated steady-state AUC₂₄ against the true value:
| Loading dose | Level after | Loading dose not entered | Loading dose entered |
|---|---|---|---|
| 2,000 mg | Dose 2 | +27% | 0% |
| 2,000 mg | Dose 3 | +16% | 0% |
| 2,000 mg | Dose 5 | +7% | 0% |
| 2,500 mg | Dose 2 | +39% | 0% |
| 2,500 mg | Dose 3 | +23% | 0% |
This patient matches the population model exactly, so entering the loading dose recovers the true value. In patients who differ from the model, one level still leaves the estimate pulled toward the population model; the automated tests check that entering the loading dose gives the same accuracy as for the same patient without one, and that leaving it out adds a consistent overestimate. A loading dose equal to the maintenance dose reproduces the equal-dose result exactly. Held, missed or changed maintenance doses are still refused rather than guessed.
500 synthetic adults per row, each given a true set of PK parameters. Levels were simulated from that truth with assay error and entered into the calculator the way a clinician would. Coverage is the share of plotted time points at which the true concentration lies inside the band (± 95% interval, accounting for repeated points in the same patient). Run on version 2026-09-25.1, 2026-09-25.
Simulations using the calculator’s assumptions
Results include only simulated cases in which the calculator displayed a band.
| Levels entered | Band shown | Coverage (target 90%) | Below / above band | At last trough | At last peak |
|---|---|---|---|---|---|
| No levels | 500 of 500 | 88.0% (±2.4) | 5.5% / 6.5% | 88.2% | 89.8% |
| One level after dose 5 | 492 of 500 | 91.0% (±1.7) | 3.4% / 5.6% | 93.3% | 91.7% |
| Loading dose, one level after dose 3 | 494 of 500 | 90.4% (±1.7) | 2.9% / 6.7% | 91.5% | 88.5% |
| Peak and trough at steady state | 500 of 500 | 90.3% (±1.8) | 2.9% / 6.8% | 91.6% | 92.0% |
Simulations with selected published variability estimates
These simulations do not reproduce the complete Colin 2019 model. They keep transfer clearance (Q) fixed, leave out the published relationships between variations in CL and V₁ and in Q and V₂, and include 21.5% proportional measurement error without the additional fixed measurement error. The tables retain the original results.
| Levels entered | Band shown | Coverage (target 90%) | Below / above band | At last trough | At last peak |
|---|---|---|---|---|---|
| No levels | 499 of 500 | 92.6% (±1.9) | 3.5% / 3.9% | 96.2% | 93.6% |
| One level after dose 5 | 495 of 500 | 87.4% (±2.0) | 4.5% / 8.1% | 87.1% | 85.5% |
| Loading dose, one level after dose 3 | 491 of 500 | 89.2% (±1.9) | 2.9% / 7.8% | 86.8% | 86.2% |
| Peak and trough at steady state | 500 of 500 | 81.8% (±2.5) | 8.3% / 9.9% | 80.4% | 84.8% |
What the results mean. Coverage was near 90% in the selected simulations using the calculator’s assumptions and lower in some simulations with changed assumptions. This does not establish reliability in patients or under the full published model. The simulated measurement error also differs from the uncertainty assumptions used when fitting blood levels. The separate error and variability sensitivity scenarios gave 84.7% and 87.1%; they used different simulated patients, so the difference cannot be attributed to the changed assumptions alone. These bands describe the model’s estimated concentration without measurement error, and the results include only cases where a band was shown. Predicting a future blood test result would require a range that also includes measurement error. That evaluation still needs independent review.
All three are written and run by the developer. None uses patient data, and none shows that Colin 2019 describes a particular population. See Evidence and methods for the full list of checks and the pending independent clinical validation.